According to the latest report published by Data Bridge Market Research, the Lipoprotein(a) Lowering Drug Market
The global lipoprotein(a) lowering drug market size was valued at USD 1.93 billion in 2025and is expected to reach USD 8.35 billion by 2033, at a CAGR of 20.10% during the forecast period
The market growth is largely driven by the rising prevalence...
